Domov › Rakovina pľúc › Kalifornia › Sacramento
Klinické štúdie Rakovina pľúc v meste Sacramento, CA
22 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v meste Sacramento a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Kaiser Permanente Downtown Commons, Sacramento
- Sutter Medical Center Sacramento, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
- a 1 ďalších
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Prebieha náborFáza 3
- Kaiser Permanente Downtown Commons, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
- Kaiser Permanente-South Sacramento, Sacramento
Distance-Based Exercise to Preserve Function and Prevent Disability
Prebieha nábor
- Kaiser Permanente-South Sacramento, Sacramento
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Mercy Cancer Center - Sacramento, Sacramento
- Woodland Memorial Hospital, Woodland · 16 míľ odtiaľ
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Prebieha náborFáza 3
- Kaiser Permanente Downtown Commons, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
- Kaiser Permanente-South Sacramento, Sacramento
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- UC Davis Comprehensive Cancer Center, Sacramento
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Prebieha náborFáza 1/2
- University of California Davis Comprehensive Cancer Center, Sacramento
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Prebieha náborFáza 1/2
- University of California Davis Comprehensive Cancer Center, Sacramento
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Prebieha náborFáza 3
- University of California Davis Comprehensive Cancer Center, Sacramento
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Prebieha náborObservačná štúdia
- University of California Davis Comprehensive Cancer Center, Sacramento
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Sutter Medical Center Sacramento, Sacramento
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Prebieha náborFáza 1
- Xencor Investigative Site, Sacramento
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- UC Davis, Davis Comprehensive Cancer Center, Sacramento
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
Prebieha náborObservačná štúdia
- University of California Davis Cancer Center, Sacramento
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Kaiser Permanente Downtown Commons, Sacramento
- Sutter Medical Center Sacramento, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- University of California, Davis Comprehensive Cancer Center, Sacramento
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- Kaiser Permanente Downtown Commons, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Sutter Medical Center Sacramento, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Prebieha náborVítaní zdravých dobrovoľníkov
- University of California, Davis · 14 míľ odtiaľ
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
Prebieha náborFáza 1
- The University of California Davis Comprehensive Cancer Center, Sacramento
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Prebieha náborFáza 1
- University of California Davis Comprehensive Cancer Center, Sacramento
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Prebieha náborFáza 1/2
- VA Northern California Health Care System, Mather, CA, Sacramento
Štúdie Rakovina pľúc v iných mestách
- Houston, TX78 štúdií
- Boston, MA62 štúdií
- New York City, NY60 štúdií
- Los Angeles, CA45 štúdií
- Arlington, VA41 štúdií
- Washington, DC41 štúdií
- Chicago, IL41 štúdií
- Baltimore, MD40 štúdií
- Nashville, TN40 štúdií
- St. Louis, MO39 štúdií
- Columbus, OH37 štúdií
- Philadelphia, PA36 štúdií
Iné štúdie v Sacramento
- Nemalobunkový karcinóm pľúc29 štúdií
- Rakovina prsníka20 štúdií
- Rakovina prostaty19 štúdií
- Metastatická rakovina16 štúdií
- Akútna myeloidná leukémia12 štúdií
- Srdcové zlyhanie12 štúdií
- Rakovina pankreasu12 štúdií
- Rakovina (všetky typy)11 štúdií
- Rakovina hrubého čreva11 štúdií
- Rakovina močového mechúra10 štúdií
- Kolorektálny karcinóm10 štúdií
- Diabetes mellitus 2. typu9 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.